Research Effect
Supports glucose regulation, insulin sensitivity, and overall metabolic function.
6 peptides documented with this effect
Research peptides documented to exhibit Metabolic Health effects in scientific studies.
Also known as: Ozempic, Wegovy, Rybelsus
A long-acting GLP-1 receptor agonist FDA-approved for type 2 diabetes and chronic weight management, achieving ~15-17% body weight reduction in clinical trials.
Also known as: Mounjaro, Zepbound, LY3298176
A first-in-class dual GIP/GLP-1 receptor agonist FDA-approved for type 2 diabetes and weight management, achieving up to ~22.5% body weight reduction.
Also known as: LY3437943, Reta
An investigational triple hormone receptor agonist (GIP/GLP-1/glucagon) that achieved up to 24.2% body weight reduction in Phase 2 trials, representing the next frontier in metabolic peptide therapy.
Also known as: Mitochondrial ORF of the Twelve S rRNA type-c
A 16-amino-acid mitochondrial-derived peptide that activates AMPK, regulates metabolic homeostasis, and enhances insulin sensitivity and exercise capacity.
Also known as: HN, HNG (S14G-Humanin)
A 24-amino-acid mitochondrial-derived peptide with cytoprotective properties, researched for protection against oxidative stress, neurodegeneration, and age-related cellular damage.
Also known as: 5-Amino-1-methylquinolinium
A small-molecule NNMT inhibitor that increases intracellular NAD+ levels and suppresses fat cell formation, researched for metabolic regulation and fat loss.